ArticlePloS one2025
Bacimethrin, an allelopathic vitamin B1 antagonist, is linked with microbial gene expression patterns in a hypereutrophic watershed.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Freshwater cyanobacterial harmful algal blooms (cyanoHABs), often dominated by Aphanizomenon, Dolichospermum, and Microcystis, are intensifying in eutrophic watersheds globally. A potential control on bacterioplankton dynamics in these systems is the availability of the essential metabolic cofactor thiamin (vitamin B1) and presence of the allelopathic thiamin antagonist bacimethrin, which causes competitive inhibition of thiamin-requiring enzymes. We examined dissolved concentrations of thiamin chemical congeners and bacimethrin, 16S amplicon-based microbiome compositions, prokaryotic mRNA-based metatranscriptomes, and reference genomes in hypereutrophic Upper Klamath Basin before and during seasonal cyanoHABs. Our objective was to connect bacterioplankton community compositions and gene expression patterns with thiamin congener and bacimethrin availability under different cyanoHAB conditions. Bacimethrin was present in all samples at similar concentrations to the thiamin precursor, HMP, suggesting that similar mechanisms influence the availability of both compounds. Additionally, bacimethrin concentrations were positively correlated with cyanoHAB species abundance (cells mL-1) and the expression of microbial thiamin biosynthesis genes. Samples with high cyanoHAB abundance also displayed elevated transcription of genes in key biochemical pathways such as the pentose phosphate pathway, photosynthesis, and glycogen biosynthesis. Bacterioplankton such as Limnohabitans spp. that are unable to synthesize thiamin, and are thus vulnerable to bacimethrin allelopathy, showed reduced gene expression when cyanoHAB abundance was high. Reference genomes of cyanoHAB and many picocyanobacteria strains contained complete thiamin biosynthesis gene pathways, implicating these taxa as major thiamin sources. These results suggest that bacimethrin provides a competitive advantage to bacterioplankton that do not require exogenous thiamin by eliminating the risk of bacimethrin uptake with thiamin transporters, potentially facilitating cyanoHAB dominance in Upper Klamath Basin and broader eutrophic watersheds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.